A phase II clinical trial of ganetespib (STA-9090) in previously treated patients with advanced esophagogastric cancers

被引：0
|
作者：
Kwak, Eunice Lee
Goyal, Lipika
Abrams, Thomas Adam
Carpenter, Amanda
Wolpin, Brian M.
Wadlow, Raymond Couric
Allen, Jill N.
Heist, Rebecca Suk
McCleary, Nadine Jackson
Chan, Jennifer A.
Goessling, Wolfram
Schrag, Deborah
Evans, Colleen
Ng, Kimmie
Enzinger, Peter C.
Ryan, David P.
机构：
[1] Massachusetts Gen Hosp Canc Ctr, Div Hematol & Oncol, Boston, MA USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp Canc Ctr, Boston, MA USA
[5] Virginia Canc Specialists, Fairfax, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4090
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer
    Lipika Goyal
    Surendra Pal Chaudhary
    Eunice L. Kwak
    Thomas A. Abrams
    Amanda N. Carpenter
    Brian M. Wolpin
    Raymond C. Wadlow
    Jill N. Allen
    Rebecca Heist
    Nadine Jackson McCleary
    Jennifer A. Chan
    Wolfram Goessling
    Deborah Schrag
    Kimmie Ng
    Peter C. Enzinger
    David P. Ryan
    Jeffrey W. Clark
    Investigational New Drugs, 2020, 38 : 1533 - 1539
  • [22] The GALAXY Trial (NCT01348126): A randomized IIB/III study of ganetespib (STA-9090) in combination with docetaxel versus docetaxel alone in subjects with stage IIIB or IV NSCLC
    Goss, Glenwood D.
    Manegold, Christian
    Rosell, Rafael
    Fennell, Dean Anthony
    Vukovic, Vojislav M.
    El-Hariry, Iman
    Teofilovici, Florentina
    Enke, Aaron S.
    Ramalingam, Suresh S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
    Kim, Chang Gon
    Sim, Nam Suk
    Kim, Jeong Eun
    Yun, Kum -Hee
    Lee, Young Han
    Kim, Seung Hyun
    Baek, Wooyeol
    Han, Yoon Dae
    Kim, Sang Kyum
    Kim, Jee Hung
    Koh, Yoon Woo
    Jung, Inkyung
    Shin, Su-Jin
    Rha, Sun Young
    Ahn, Jin-Hee
    Kim, Hyo Song
    CLINICAL CANCER RESEARCH, 2022, 28 (15) : 3225 - 3234
  • [24] CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach
    Harald Schmalenberg
    Salah-Eddin Al-Batran
    Claudia Pauligk
    Thomas Zander
    Alexander Reichart
    Udo Lindig
    Mathias Kleiß
    Lothar Müller
    Claus Bolling
    Thomas Seufferlein
    Peter Reichardt
    Frank Kullmann
    Henning Eschenburg
    Alexander Schmittel
    Matthias Egger
    Andreas Block
    Thorsten Oliver Goetze
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 559 - 569
  • [25] CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach
    Schmalenberg, Harald
    Al-Batran, Salah-Eddin
    Pauligk, Claudia
    Zander, Thomas
    Reichart, Alexander
    Lindig, Udo
    Kleiss, Mathias
    Mueller, Lothar
    Bolling, Claus
    Seufferlein, Thomas
    Reichardt, Peter
    Kullmann, Frank
    Eschenburg, Henning
    Schmittel, Alexander
    Egger, Matthias
    Block, Andreas
    Goetze, Thorsten Oliver
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (03) : 559 - 569
  • [26] Phase II Trial of Single Agent Amrubicin in Patients with Previously Treated Advanced Thymic Malignancies
    Wakelee, Heather A.
    Padda, Sukhmani K.
    Burns, Matthew
    Spittler, A. J.
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Ramchandran, Kavitha J.
    Gubens, Matthew A.
    Neal, Joel W.
    Loehrer, Patrick J.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S195 - S195
  • [27] Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies
    Hellyer, Jessica A.
    Gubens, Matthew A.
    Cunanan, Kristen M.
    Padda, Sukhmani K.
    Burns, Matthew
    Spittler, A. John
    Riess, Jonathan W.
    San Pedro-Salcedo, Melanie
    Ramchandran, Kavitha J.
    Neal, Joel W.
    Wakelee, Heather A.
    Loehrer, Patrick J., Sr.
    LUNG CANCER, 2019, 137 : 71 - 75
  • [28] Phase II Trial of Enfortumab Vedotin in Patients With Previously Treated Advanced Head and Neck Cancer
    Swiecicki, Paul L.
    Yilmaz, Emrullah
    Rosenberg, Ari Joseph
    Fujisawa, Takao
    Bruce, Justine Yang
    Meng, Changting
    Wozniak, Michele
    Zhao, Yongyun
    Mihm, Michael
    Kaplan, Jason
    Gorla, Seema
    Geiger, Jessica L.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (05)
  • [29] A Phase II Trial of Docetaxel and Vinorelbine in Patients with Advanced Breast Cancer Previously Treated with Anthracyclines
    Vici, Patrizia
    Di Lauro, Luigi
    Sergi, Domenico
    Foggi, Paolo
    Viola, Giuditta
    Mottolese, Marcella
    Giotta, Francesco
    Fattoruso, Silvia I. S.
    Corsetti, Serena
    Giannarelli, Diana
    Botti, Claudio
    Lopez, Massimo
    ONCOLOGY, 2008, 75 (3-4) : 175 - 181
  • [30] QUALITY OF LIFE ANALYSIS IN THE GALAXY TRIALTM (NCT01348126): A RANDOMIZED PHASE IIB/III STUDY OF GANETESPIB (STA-9090) IN COMBINATION WITH DOCETAXEL VERSUS DOCETAXEL ALONE IN PATIENTS WITH STAGE IIIB OR IV NSCLC
    Andric, Z. G.
    Havel, L.
    Di Hariry, I.
    Vukovic, V.
    Teofilovici, F.
    Guo, W.
    Mulcahey, S.
    Bradley, R.
    Ceric, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 436 - 436
12345